Literature DB >> 9512544

Baculovirus surface display: construction and screening of a eukaryotic epitope library.

W Ernst1, R Grabherr, D Wegner, N Borth, A Grassauer, H Katinger.   

Abstract

The baculovirus expression system was utilized to serve as a tool for ligand selection, demonstrating the applicability of the system to the generation and screening of eukaryotic expression libraries. The HIV-1-gp41 epitope 'ELDKWA', specific for the neutralizing human mAb 2F5, was inserted into the antigenic site B of influenza virus hemagglutinin and expressed on the surface of baculovirus infected insect cells. In order to improve the antigenicity of the epitope within the hemagglutinin, and therefore enhance the specific binding of 2F5, we inserted three additional, random amino acids adjacent to the epitope. This pool of hemagglutinin genes was directly cloned into the baculovirus Ac-omega. To identify distinct proteins displayed on the cellular surface, we developed a screening protocol to select for specific binding capacity of individual viral clones. Using fluorescence activated cell sorting (FACS) we isolated a baculovirus clone displaying the epitope with markedly increased binding capacity out of a pool of 8000 variants in only one sorting step. Binding properties of the identified ligand were examined by FACS performing a competition assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512544      PMCID: PMC147480          DOI: 10.1093/nar/26.7.1718

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Expression of foreign epitopes on recombinant occlusion bodies of baculoviruses.

Authors:  J H McLinden; V A Ploplis; M J Fraser; E D Rosen
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

3.  Cationic lipid-mediated co-transfection of insect cells.

Authors:  D R Groebe; A E Chung; C Ho
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

4.  Retarded processing of influenza virus hemagglutinin in insect cells.

Authors:  K Kuroda; M Veit; H D Klenk
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

5.  Characterization of the human transferrin receptor produced in a baculovirus expression system.

Authors:  D L Domingo; I S Trowbridge
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

6.  Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1.

Authors:  S Li; V Polonis; H Isobe; H Zaghouani; R Guinea; T Moran; C Bona; P Palese
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells.

Authors:  H Ghiasi; A B Nesburn; S L Wechsler
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

8.  By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro.

Authors:  H R Hoogenboom; G Winter
Journal:  J Mol Biol       Date:  1992-09-20       Impact factor: 5.469

9.  Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.

Authors:  Y Boublik; P Di Bonito; I M Jones
Journal:  Biotechnology (N Y)       Date:  1995-10

10.  Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector.

Authors:  K Kuroda; C Hauser; R Rott; H D Klenk; W Doerfler
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

View more
  26 in total

1.  Using a baculovirus display library to identify MHC class I mimotopes.

Authors:  Yibing Wang; Anatoyla Rubtsov; Ryan Heiser; Janice White; Frances Crawford; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

2.  Baculovirus display of functional antibody Fab fragments.

Authors:  Shinya Takada; Takafumi Ogawa; Kazusa Matsui; Tasuku Suzuki; Tomohisa Katsuda; Hideki Yamaji
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

Review 3.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

Review 4.  Applications of Yeast Surface Display for Protein Engineering.

Authors:  Gerald M Cherf; Jennifer R Cochran
Journal:  Methods Mol Biol       Date:  2015

5.  Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.

Authors:  Mikyung Kim; Zhisong Qiao; Jessica Yu; David Montefiori; Ellis L Reinherz
Journal:  Vaccine       Date:  2006-10-09       Impact factor: 3.641

Review 6.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

7.  Structural Organization of Baculovirus Occlusion Bodies and Protective Role of Multilayered Polyhedron Envelope Protein.

Authors:  Dayanand B Sajjan; Shivayogeppa B Hinchigeri
Journal:  Food Environ Virol       Date:  2016-01-19       Impact factor: 2.778

8.  Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct.

Authors:  Jian Zhou; Gary W Blissard
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.

Authors:  S Phogat; K Svehla; M Tang; A Spadaccini; J Muller; J Mascola; I Berkower; R Wyatt
Journal:  Virology       Date:  2007-12-26       Impact factor: 3.616

10.  The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins.

Authors:  A G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.